Form 8-K · Current report
Lululemon Athletica 8-K, filed Sep 3, 2026
- Filed
- CIK
- 0001397187
- Accession no.
- 0001397187-26-000126
Summary
Lululemon Athletica reported second-quarter fiscal 2026 net revenue fell 4% to $2.4 billion and comparable sales fell 9%, with diluted EPS of $2.92, and cut its full-year outlook to revenue of $10.35–10.50 billion (a 5–7% decline) and EPS of $9.48–9.73. Interim co-CEOs Meghan Frank and André Maestrini said the company is taking a prudent approach with the revised outlook, and said incoming CEO Heidi O'Neill joins the following week.
Key points
- Second-quarter gross margin rose 200 basis points to 60.5%, including $134.5 million of IEEPA tariff refunds that added 560 basis points.
- Americas net revenue fell 8% while international net revenue rose 4%, or 2% on a constant dollar basis.
- The company repurchased 2.7 million shares for $330.0 million and opened nine net new company-operated stores, ending with 825.
- Third-quarter fiscal 2026 guidance is net revenue of $2.290–2.320 billion, a 10–11% decline, and diluted EPS of $0.93–0.98.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On September 3, 2026, lululemon athletica inc. (the "Company") issued a press release announcing its financial results for the second quarter ended August 2, 2026 and certain other information. A copy of the Company's press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. As previously announced, the Company has scheduled a conference call for 4:30 p.m. Eastern time on September 3, 2026 to discuss its financial results. Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release issued on September 3, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.